Neuberger Berman Group »

Cytek Biosciences shares owned by Neuberger Berman Group

Quarter-by-quarter ownership of Cytek Biosciences (CTKB) shares owned by Neuberger Berman Group from 13F filings

Historical chart of Neuberger Berman Group investment in Cytek Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cytek Biosciences held by Neuberger Berman Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytek Biosciences by Neuberger Berman Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $63k 12k 5.05
2025-03-31 $56k 14k 4.01

More positions owned by Neuberger Berman Group

Microsoft Corp Common (MSFT)
Nvidia Corp Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Alphabet Inc Class A A Common (GOOGL)
Alphabet Inc-cl C Common (GOOG)
Jan28 Now P @ 120.000000 Option Put Option (NOW)
Jpmorgan Chase & Co Common (JPM)
Eli Lilly & Co Common (LLY)
February 26 Calls on HD US Option Call Option (HD)
Meta Platforms Inc Class A A Common (META)
Broadcom Common (AVGO)
Ishares Core S&p 500 Etf Etf (IVV)
Nextera Energy Common (NEE)
Visa Inc-class A Shares Common (V)

View all positions for Neuberger Berman Group

Top funds holding Cytek Biosciences

BlackRock
Vanguard Group
Hillhouse Capital Advisors
Robeco Investment Management
State Street Corporation
Millennium Management
Geode Capital Management
Dimensional Fund Advisors
Wellington Management Company
Brown Capital Management
Goldman Sachs Group
Royce & Associates
Charles Schwab Investment Management
AQR Capital Management
Russell Investments

View all funds holding Cytek Biosciences